Searched for
NPPA DRUG PRICES
'Inflated medicine prices are daylight robbery': SC pulls up pharma companies over huge MRP-PTR gapSupreme Court on Tuesday questioned the wide gap between the price to retailer and MRP of some cancer medicines, calling inflated pricing a...- Hospitals seek new pricing rules as Maharashtra FDA flags high markupsThe healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procu...
- Centre seeks NPPA report on high markups in hospital consumablesThe Centre has requested a report from the NPPA regarding price discrepancies. Maharashtra FDA flagged significant gaps between trade price...
- Rs 11 IV for Rs 325, Rs 6 syringe for Rs 57: Tukaram Mundhe flags 2,841% inflated hospital bills that patients don't even know, sends recommendation to CentreMaharashtra FDA Commissioner Tukaram Mundhe has cited a survey showing substantial differences between procurement prices and printed MRPs ...
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
- Drugmakers may bear sole responsibility for overpricing essential medicines under NPPA proposalThe National Pharmaceutical Pricing Authority aims to hold drug manufacturers solely accountable for the excessive pricing of essential med...
- Maharashtra FDA trains guns on overpriced drugsMaharashtra FDA plans to approach the NPPA regarding exorbitant drug prices. The agency is examining data and will take action against unet...
- New rules simplify drug launches, reduce manufacturer liability for overchargingNew rules now allow drug manufacturers to launch similar medicines without prior price approval, streamlining market entry. Companies can s...
- NPPA hauled up for hiking drug pricesIndia's parliamentary committee criticized the drug pricing regulator for approving a 50% price increase on 11 drug formulations in October...
- NPPA approves price rise of 50 per cent for carbamazepine, ranitidine, ibuprofenNPPA, in its meeting on June 28, deliberated upon the case of upward price revision of the formulations of these drugs under Para 19 of DPC...
- The tightrope walk of India's drug-price regulatorET Online retraces here the tenures of NPPA chiefs. The question to ask: Is taking on the pharma and healthcare lobby injurious to the NPPA...
- NPPA fixes retail price of 30 drug formulationsThe National Pharmaceutical Pricing Authority (NPPA) has also revised the prices of three formulations, including that of anti cancer drug ...
- No plans to revamp NPPA: GovernmentIn a written reply to a question in the Rajya Sabha, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said the governmen...
- NPPA may lose absolute power to fix drug prices under new policyNPPA presently functions as an autonomous body that regulates prices of medicines under National List of Essential Medicines and monitors p...
- Drug watchdog NPPA stripped of some of its key powersSolicitor-General Ranjit Kumar’s opinion said the regulator had exceeded powers by cutting price of non-essential drugs.
- NPPA seeks states' participation to keep drug prices under controlThis comes close on the heels of National Pharma Pricing Authority's (NPPA) plans to lower prices of expensive medicines used for select th...
- Pricing of imported drugs under regulatory scannerNPPA has initiated a process to end the freedom enjoyed by drug makers to fix the retail price of their imported medicines.
- Higher prices for 70 drugsThe government may agree to price increases in 70 scheduled drugs and revise those of several bulk drugs.
- Gujarat HC stays NPPA order to cut price of Cadila drug EnvasThe Gujarat HC has stayed a decision of the drug price regulator National Pharmaceutical Pricing Authority to lower the price of Ahmedabad-...
- NPPA may lose some autonomyDrug price regulator the National Pharmaceutical Pricing Authority (NPPA) may lose some of its autonomy soon.
Load More
